Header cover image

Chinese (SSE) Drug Retail Industry Analysis

UpdatedSep 26, 2025
DataAggregated Company Financials
Companies9
  • 7D-3.8%
  • 3M-3.5%
  • 1Y15.6%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 3.2%, driven by pullbacks from every company within the industry. This takes the industry's 12 month performance to a gain of 33%. Looking forward, earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Chinese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Sep 2025CN¥88.2bCN¥120.6bCN¥3.3b30.1x26.5x0.7x
Sun, 24 Aug 2025CN¥92.5bCN¥120.5bCN¥3.2b31.4x29.3x0.8x
Tue, 22 Jul 2025CN¥91.2bCN¥120.4bCN¥3.3b31.3x28x0.8x
Thu, 19 Jun 2025CN¥91.1bCN¥120.4bCN¥3.3b30.5x28x0.8x
Sat, 17 May 2025CN¥94.3bCN¥120.4bCN¥3.3b30.4x28.9x0.8x
Mon, 14 Apr 2025CN¥92.3bCN¥121.0bCN¥3.9b22.7x23.8x0.8x
Wed, 12 Mar 2025CN¥86.5bCN¥121.0bCN¥3.9b19.7x22.2x0.7x
Fri, 07 Feb 2025CN¥81.3bCN¥121.0bCN¥3.9b18.6x20.8x0.7x
Sun, 05 Jan 2025CN¥80.5bCN¥121.0bCN¥3.9b18.9x20.6x0.7x
Tue, 03 Dec 2024CN¥91.0bCN¥121.0bCN¥3.9b20.1x23.3x0.8x
Thu, 31 Oct 2024CN¥82.3bCN¥119.9bCN¥4.1b18.4x20x0.7x
Sat, 28 Sep 2024CN¥81.8bCN¥119.6bCN¥4.3b18.7x18.9x0.7x
Mon, 26 Aug 2024CN¥68.1bCN¥118.4bCN¥4.8b15.3x14.2x0.6x
Wed, 24 Jul 2024CN¥77.0bCN¥118.4bCN¥4.8b18.1x16.1x0.7x
Fri, 21 Jun 2024CN¥95.3bCN¥118.4bCN¥4.8b22.9x19.9x0.8x
Sun, 19 May 2024CN¥126.9bCN¥118.3bCN¥4.8b26.4x26.6x1.1x
Tue, 16 Apr 2024CN¥119.7bCN¥114.8bCN¥5.2b22.5x23x1x
Thu, 14 Mar 2024CN¥118.1bCN¥115.9bCN¥5.8b20x20.3x1x
Sat, 10 Feb 2024CN¥122.1bCN¥116.0bCN¥5.7b20.5x21.3x1.1x
Mon, 08 Jan 2024CN¥130.9bCN¥116.0bCN¥5.7b22.7x22.8x1.1x
Wed, 06 Dec 2023CN¥128.2bCN¥116.0bCN¥5.7b22.7x22.4x1.1x
Fri, 03 Nov 2023CN¥118.5bCN¥115.8bCN¥5.7b21.6x20.7x1x
Sun, 01 Oct 2023CN¥120.4bCN¥113.6bCN¥5.7b23.1x21.2x1.1x
Tue, 29 Aug 2023CN¥122.5bCN¥111.0bCN¥5.5b25.7x22.2x1.1x
Thu, 27 Jul 2023CN¥129.9bCN¥109.7bCN¥5.4b27.4x23.9x1.2x
Sat, 24 Jun 2023CN¥132.1bCN¥109.7bCN¥5.4b27.8x24.3x1.2x
Mon, 22 May 2023CN¥132.1bCN¥109.7bCN¥5.4b27.3x24.3x1.2x
Wed, 19 Apr 2023CN¥141.3bCN¥95.3bCN¥4.4b37.4x32x1.5x
Fri, 17 Mar 2023CN¥142.9bCN¥90.3bCN¥4.0b35x35.5x1.6x
Sun, 12 Feb 2023CN¥138.0bCN¥90.3bCN¥4.0b34.1x34.3x1.5x
Tue, 10 Jan 2023CN¥151.8bCN¥90.3bCN¥4.0b39x37.7x1.7x
Thu, 08 Dec 2022CN¥156.4bCN¥90.3bCN¥4.0b39.9x38.8x1.7x
Sat, 05 Nov 2022CN¥141.8bCN¥90.3bCN¥4.0b42x35.5x1.6x
Mon, 03 Oct 2022CN¥113.2bCN¥85.6bCN¥3.8b35.1x29.6x1.3x
Price to Earnings Ratio

29.6x


Total Market Cap: CN¥113.2bTotal Earnings: CN¥3.8bTotal Revenue: CN¥85.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Drug Retail Industry Price to Earnings3Y Average 25.1x202320242025
Current Industry PE
  • Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 25.1x.
  • The 3-year average PS ratio of 1.0x is higher than the industry's current PS ratio of 0.74x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 4.4% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Drug Retail compare with similar industries?

CN Market0.98%
Consumer Staples-2.39%
Food and Staples Retail-5.50%
Drug Retail-3.78%
Big Box Super Stores-3.05%
Food Distributors-3.19%
Food Retail-6.67%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News